Literature DB >> 7573239

Transport of immunoglobulin G and its subclasses across the in vitro-perfused human placenta.

A Malek1, R Sager, A Zakher, H Schneider.   

Abstract

OBJECTIVE: The transport of immunoglobulin G and its subclasses 1 to 4 was investigated in the in vitro-perfused isolated cotyledon of the human placenta. STUDY
DESIGN: An in vitro system with separate perfusion of the villous capillary system (fetal compartment) and the corresponding intervillous space (maternal compartment) was set up in an isolated cotyledon of human term placenta. After a 2-hour control phase with both compartments perfused in a closed circuit with NCTC-135 tissue culture medium together with Earl's balanced salt solution (2:1), media were exchanged in both circuits and for the experimental phase immunoglobulin G (Sandoglobulin) together with carbon 14-labeled bovine serum albumin (5-10 microCi) was added to the maternal compartment at a concentration of 6 gm/L. During the experimental phase, lasting between 2 and 5 hours, samples were taken from the maternal and fetal compartments every 30 minutes up to 2 hours and every 60 minutes thereafter.
RESULTS: During the control phase immunoglobulin G appeared in the maternal perfusate and reached a plateau at 60 to 80 mg/L, whereas the concentration in the fetal perfusate did not exceed 20 mg/L. A similar pattern of release was observed for hemoglobin, suggesting a washout of remains of blood from the intervillous space and the villous vascular compartment. After addition of immunoglobulin G to the maternal circuit during the first 2 hours in three of four experiments, no change in immunoglobulin G concentration was seen in the fetal circuit, and only in the fourth and fifth hours did the fetal concentration increase to 0.6% of the maternal concentration. In contrast, carbon 14-labeled bovine serum albumin was already detectable in the fetal circuit after 1 hour, but the level remained constant at 0.1% of the maternal concentration. Total immunoglobulin G transfer was estimated at 0.5% of the amount added to the maternal circulation, which was five times higher than total transfer of bovine serum albumin. Transfer was shown for all four subclasses. At the end of the experiment the ratio of immunoglobulin G1 to immunoglobulin G2 in the fetal perfusate was significantly higher than in the maternal perfusate (3.8 vs 1.8), suggesting preferential transfer of immunoglobulin G1.
CONCLUSION: Transfer of all four immunoglobulin G subclasses of a commercially available immunoglobulin G preparation across the human placenta from the maternal to the fetal side was demonstrated by the dual in vitro perfusion system. There is a preferential transfer for immunoglobulin G1.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7573239     DOI: 10.1016/0002-9378(95)90336-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  10 in total

Review 1.  Transcytosis and catabolism of antibody.

Authors:  Victor Ghetie; E Sally Ward
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Expression of placental alkaline phosphatase does not correlate with IgG binding, internalization and transcytosis.

Authors:  I Stefaner; A Stefanescu; W Hunziker; R Fuchs
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

Review 3.  HFcRn-mediated transplacental immunoglobulin G transport: protection of and threat to the human fetus and newborn.

Authors:  Isabella Ellinger; Renate Fuchs
Journal:  Wien Med Wochenschr       Date:  2012-05

Review 4.  Pemphigus and pregnancy. Analysis and summary of case reports over 49 years.

Authors:  Lin Lin; Xin Zeng; Qianming Chen
Journal:  Saudi Med J       Date:  2015-09       Impact factor: 1.484

5.  New onset pemphigus foliaceus during pregnancy: A rare case.

Authors:  M Kokolios; F Lamprou; D Stylianidou; D Sotiriadis; A Patsatsi
Journal:  Int J Womens Dermatol       Date:  2017-12-08

Review 6.  Hormonal Regulation of Physiology, Innate Immunity and Antibody Response to H1N1 Influenza Virus Infection During Pregnancy.

Authors:  Elizabeth Q Littauer; Ioanna Skountzou
Journal:  Front Immunol       Date:  2018-10-29       Impact factor: 7.561

Review 7.  The Neonatal Fc Receptor (FcRn): A Misnomer?

Authors:  Michal Pyzik; Kine M K Sand; Jonathan J Hubbard; Jan Terje Andersen; Inger Sandlie; Richard S Blumberg
Journal:  Front Immunol       Date:  2019-07-10       Impact factor: 7.561

Review 8.  A Review of Nanotechnology for Treating Dysfunctional Placenta.

Authors:  Huabo Jiang; Li Li; Dan Zhu; Xinyao Zhou; Yongsheng Yu; Qian Zhou; Luming Sun
Journal:  Front Bioeng Biotechnol       Date:  2022-03-24

Review 9.  In Translation: FcRn across the Therapeutic Spectrum.

Authors:  Timothy Qi; Yanguang Cao
Journal:  Int J Mol Sci       Date:  2021-03-17       Impact factor: 5.923

10.  Anti-RBD IgA and IgG Response and Transmission in Breast Milk of Anti-SARS-CoV-2 Vaccinated Mothers.

Authors:  Felicia Trofin; Eduard Vasile Nastase; Luminita Smaranda Iancu; Daniela Constantinescu; Corina Maria Cianga; Catalina Lunca; Ramona Gabriela Ursu; Petru Cianga; Olivia Simona Dorneanu
Journal:  Pathogens       Date:  2022-02-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.